Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke

Hoth Therapeutics Partners Altasciences For Study On HT-KIT Cancer Treatment

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday that it has completed bioanalytical method development under its prior agreement with Altasciences.

RTTNews | 625 일 전

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.

RTTNews | 793 일 전

Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

RTTNews | 1049 일 전

CAC 40 Extends Gains To 3rd Straight Day, Rises Over 1%

French stocks are up in positive territory on Wednesday, extending gains to a third straight session, led by gains in financial and luxury sectors. Expectations of an interest rate cut by the Federal Reserve next month, and hopes that the government shutdown in the U.S. will likely end this week help underpin sentiment.

RTTNews | 1 시간 15 분 전

DAX Climbs To 4-week High On Inflation Data, Earnings

EURUSD	1.15773	GBPUSD	1.31353	AUDUSD	0.65351
USDJPY	154.814	USDCAD	1.40176	USDCHF	0.7988

Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke

Hoth Therapeutics Partners Altasciences For Study On HT-KIT Cancer Treatment

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

CAC 40 Extends Gains To 3rd Straight Day, Rises Over 1%

DAX Climbs To 4-week High On Inflation Data, Earnings

Sensex, Nifty Surge On Trade Deal Hopes; IT Stocks Lead Gains

Yen Falls After Japan PM Takaichi Comments

European Shares Climb On Hopes Of US Shutdown Ending